Vireo Growth (VREOF) Other Non-Current Assets (2020 - 2026)

Vireo Growth (VREOF) reported Other Non-Current Assets of $4.4 million for Q1 2026, up 944.53% on a YoY basis from $421244.0 in Q1 2025, and little changed sequentially from $4.4 million in Q4 2025.

Vireo Growth (VREOF) Other Non-Current Assets (2020 - 2026) Analysis & Trends

Vireo Growth (VREOF) has 7 years of Other Non-Current Assets data on file, last reported at $4.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Assets rose 944.53% year-over-year to $4.4 million; the trailing twelve-month figure through Mar 2026 stood at $4.4 million (up 944.53% YoY), and the FY2025 full-year result was $4.4 million, up 944.53% from the prior year.
  • Other Non-Current Assets held at $4.4 million in Q1 2026, from $4.4 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $4.4 million in Q4 2025 to a low of $328166.0 in Q2 2025.
  • A 5-year average of $1.4 million and a median of $533745.0 in 2024 frame the typical range for Other Non-Current Assets.
  • Across the five-year window, Other Non-Current Assets sank 83.41% in 2023 and jumped 944.53% in 2025, its largest moves.
  • Tracing VREOF's Other Non-Current Assets over 5 years: stood at $2.3 million in 2022, then slumped by 83.41% to $383645.0 in 2023, then increased by 9.8% to $421244.0 in 2024, then jumped by 944.53% to $4.4 million in 2025, then changed by 0.0% to $4.4 million in 2026.
  • Business Quant data shows VREOF's Other Non-Current Assets at $4.4 million in Q1 2026, $4.4 million in Q4 2025, and $2.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 4.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.40 Mn
Dec 31, 2025 4.40 Mn
Sep 30, 2025 2.13 Mn
Jun 30, 2025 328,166.00
Mar 31, 2025 421,244.00
Dec 31, 2024 421,244.00
Sep 30, 2024 533,745.00
Jun 30, 2024 533,745.00
Mar 31, 2024 533,745.00
Dec 31, 2023 383,645.00
Sep 30, 2023 383,645.00
Jun 30, 2023 383,645.00
Mar 31, 2023 593,812.00
Dec 31, 2022 2.31 Mn
Sep 30, 2022 2.18 Mn
Jun 30, 2022 2.12 Mn
Mar 31, 2022 1.99 Mn
Dec 31, 2021 1.72 Mn
Sep 30, 2021 1.34 Mn
Jun 30, 2021 1.41 Mn